Epetraborole in Patients With Mycobacterium Abscessus Lung Disease
Epetraborole in Patients With Mycobacterium Abscessus Lung Disease
Recruiting · NCT07301320 · Registry updated 2026-05-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Epetraborole in Patients With Mycobacterium Abscessus Lung Disease | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, Mycobacterium Infections, Nontuberculous, Mycobacterium abscessus Infection, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease | Recruiting | Phase 2 | 2026-05-06 | NCT07301320 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AN2 Therapeutics, Inc | 1 |
| Kevin Winthrop | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Oregon Health & Science University | Portland | United States | 261 |